145 related articles for article (PubMed ID: 16424345)
1. Plasminogen activator inhibitor-1 gene: selection of tagging single nucleotide polymorphisms and association with coronary heart disease.
Su S; Chen S; Zhao J; Huang J; Wang X; Chen R; Gu D
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):948-54. PubMed ID: 16424345
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive survey of common genetic variation at the plasminogen activator inhibitor-1 locus and relations to circulating plasminogen activator inhibitor-1 levels.
Kathiresan S; Gabriel SB; Yang Q; Lochner AL; Larson MG; Levy D; Tofler GH; Hirschhorn JN; O'Donnell CJ
Circulation; 2005 Sep; 112(12):1728-35. PubMed ID: 16172282
[TBL] [Abstract][Full Text] [Related]
3. A-G-4G haplotype of PAI-1 gene polymorphisms -844 G/A, HindIII G/C, and -675 4G/5G is associated with increased risk of ischemic stroke caused by small vessel disease.
Adamski MG; Turaj W; Slowik A; Wloch-Kopec D; Wolkow P; Szczudlik A
Acta Neurol Scand; 2009 Aug; 120(2):94-100. PubMed ID: 19154538
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between polymorphisms of plasminogen activator inhibitor-1 promoter gene and pulmonary thromboembolism in Chinese Han population].
Zhai ZG; Wang C; Yang YH; Pang BS; Xiao B; Liu YM; Mao YL; Weng XZ
Zhonghua Yi Xue Za Zhi; 2006 May; 86(19):1313-7. PubMed ID: 16796899
[TBL] [Abstract][Full Text] [Related]
5. 4G/5G polymorphism and haplotypes of SERPINE1 in atherosclerotic diseases of coronary arteries.
Koch W; Schrempf M; Erl A; Mueller JC; Hoppmann P; Schömig A; Kastrati A
Thromb Haemost; 2010 Jun; 103(6):1170-80. PubMed ID: 20352162
[TBL] [Abstract][Full Text] [Related]
6. Association study of ACE2 (angiotensin I-converting enzyme 2) gene polymorphisms with coronary heart disease and myocardial infarction in a Chinese Han population.
Yang W; Huang W; Su S; Li B; Zhao W; Chen S; Gu D
Clin Sci (Lond); 2006 Nov; 111(5):333-40. PubMed ID: 16822235
[TBL] [Abstract][Full Text] [Related]
7. Diabetic retinopathy, PAI-1 4G/5G and -844G/A polymorphisms, and changes in circulating PAI-1 levels in Tunisian type 2 diabetes patients.
Ezzidi I; Mtiraoui N; Chaieb M; Kacem M; Mahjoub T; Almawi WY
Diabetes Metab; 2009 Jun; 35(3):214-9. PubMed ID: 19419896
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms at FCER1B and PAI-1 and asthma susceptibility.
Hizawa N; Maeda Y; Konno S; Fukui Y; Takahashi D; Nishimura M
Clin Exp Allergy; 2006 Jul; 36(7):872-6. PubMed ID: 16839401
[TBL] [Abstract][Full Text] [Related]
9. Single nucleotide polymorphisms in promoter of angiotensin II type 1 receptor gene associated with essential hypertension and coronary heart disease in Chinese population.
Jin W; Liu Y; Sheng HH; Jin L; Shen YY; Hua Q; Lu L; Yu JD; Huang W
Acta Pharmacol Sin; 2003 Nov; 24(11):1083-8. PubMed ID: 14627489
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphism of the plasminogen activator inhibitor-1 is associated with an increased risk of endometrial cancer.
Su CK; Yeh KT; Yeh CB; Wang PH; Ho ES; Chou MC; Liu KC; Yang SF; Yi YC
J Surg Oncol; 2011 Dec; 104(7):755-9. PubMed ID: 21761413
[TBL] [Abstract][Full Text] [Related]
11. Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in Turkish patients with generalized aggressive periodontitis.
Emingil G; Berdeli A; Gürkan A; Han Saygan B; Köse T; Atilla G
J Clin Periodontol; 2007 Apr; 34(4):278-84. PubMed ID: 17257155
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator inhibitor-1 polymorphism (4G/5G) predicts recurrence in nonhyperlipidemic postinfarction patients.
Corsetti JP; Ryan D; Moss AJ; Rainwater DL; Zareba W; Sparks CE
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):548-54. PubMed ID: 18096824
[TBL] [Abstract][Full Text] [Related]
13. [Association of PAI-1 gene polymorphism with prognosis of coronary artery disease].
Zhang AY; Ji XW; Guan LX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):233-5. PubMed ID: 18393255
[TBL] [Abstract][Full Text] [Related]
14. Epistatic effect of plasminogen activator inhibitor 1 and beta-fibrinogen genes on risk of glomerular microthrombosis in lupus nephritis: interaction with environmental/clinical factors.
Gong R; Liu Z; Li L
Arthritis Rheum; 2007 May; 56(5):1608-17. PubMed ID: 17469143
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.
Jorgenson E; Deitcher SR; Cicek M; Liu X; Plummer S; Casey G; Witte JS
Prostate; 2007 Feb; 67(2):172-7. PubMed ID: 17044080
[TBL] [Abstract][Full Text] [Related]
16. Impact of plasminogen activator inhibitor-1 gene polymorphisms on primary membranous nephropathy.
Chen CH; Shu KH; Wen MC; Chen KJ; Cheng CH; Lian JD; Wu MJ; Yu TM; Tsai FJ
Nephrol Dial Transplant; 2008 Oct; 23(10):3166-73. PubMed ID: 18495745
[TBL] [Abstract][Full Text] [Related]
17. SERPINE1 intron polymorphisms affecting gene expression are associated with diffuse-type gastric cancer susceptibility.
Ju H; Lim B; Kim M; Noh SM; Kim WH; Ihm C; Choi BY; Kim YS; Kang C
Cancer; 2010 Sep; 116(18):4248-55. PubMed ID: 20549826
[TBL] [Abstract][Full Text] [Related]
18. [Association of interleukin-1B gene polymorphisms with coronary heart disease].
Zhu YH; Xu YC; Zhou B; Liang WB; Wang YY; Gao LB; Zhang L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 40(1):73-6. PubMed ID: 19292049
[TBL] [Abstract][Full Text] [Related]
19. Combined effects of apoE-CI-CII cluster and LDL-R gene polymorphisms on chromosome 19 and coronary artery disease risk.
Wang C; Zhou X; Ye S; Han D; Tan X; Zheng F; Shi Q
Int J Hyg Environ Health; 2006 May; 209(3):265-73. PubMed ID: 16459141
[TBL] [Abstract][Full Text] [Related]
20. [Genetic association of apoE and apoCI gene polymorphisms with coronary heart disease].
Wang CH; Zhou X; Zhou GD; Tan XD; Han DF; Zheng F; Liu F
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Nov; 25(11):982-5. PubMed ID: 15769335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]